Klonetics Strengthens Industry Position with Custom Craft Grow Services to licensed producers in Canada and Abroad
We are thrilled to announce a major milestone in our journey to become a vertically integrated cannabis company serving the needs of the industry in Canada, and abroad.
2023 has been a remarkable year for Klonetics marked by significant milestones that have paved the way for our expansion and growth. Most recently, we secured a two year contract with a large licensed producer to custom grow premium craft cannabis. This partnership extends their market reach in the premium craft cannabis category and allows them to offer new and exciting cultivars. The deal will showcase the best genetics in the Klonetics library and demonstrate our commitment to superior quality plants meticulously nurtured from tissue to flower.
Additionally, this year we broadened our global reach by establishing a strategic partner facility in Portugal. This expansion was complemented by a groundbreaking agreement with an International medical cannabis company to provide custom flower, further solidifying our position as a global cannabis company. Earlier this month, we also successfully completed our IMC-GAP certification.
Custom contract growing of premium flower represents a new and increasing line of business for Klonetics and will continue to grow in 2024. As Klonetics begins to support more customers globally, we will continue to address the unique needs of each market by providing fresh and stable premium genetics that drive meaningful profit for our customers, while exceeding regulatory requirements in each region we operate in.
At Klonetics, we're not just growing cannabis; we're cultivating excellence, scientific innovation, and a brighter future for the global cannabis industry.
Stay connected with us for more exciting updates on our
LinkedIn page.
Share this article with your network:
